Jun 26, 2023 | LIPIDS
1b) Patients with #diabetes are at substantially increased risk of #CV disease, often in association with hyperlipidemia #HL. Therefore it's no surprise that a 🌶️topic at #ADA2023 would be management of #HL and #CV disease prevention!#FOAMed @MedTweetorials—...
Jun 24, 2023 | LIPIDS
1b) Patients with #diabetes #PWDs are of course at substantially increased risk of #CV disease, often in association with hyperlipidemia #HL. Therefore it's no surprise that a 🌶️topic at #ADA23 would be management of #HL and #CV disease prevention!#FOAMed...
Jun 2, 2023 | LIPIDS
1b) Dr. Taub is a clinician/scientist and is a frequent contributor to our #accredited programs. She is the founding director of the Step Family Foundation Cardiac Rehabilitation and Wellness Center at #UCSD.#FOAMed #cardiotwitter @medtweetorials #MedEd #lipids...
Mar 6, 2023 | LIPIDS
1a) Welcome to a two-part (today and Monday) live-tweeted, #accredited #tweetorial on 2⃣ 🔑#LBCTs from @ACCinTouch #ACC23 in #NewOrleans 🥳on advances in #hyperlipidemia management #LLT. Our expert presenter and commentator is none other than @CMichaelGibson....
Sep 6, 2022 | LIPIDS
2a) This is the next instalment of @cardiomet_CE‘s 10-part foundational series on #lipid_management! It is accredited for #CME/CE and intended for #physicians #physicianassociates #nurses #nursepractitioners #pharmacists. #FOAMed @MedTweetorials #cardiotwitter—...
Jul 29, 2022 | LIPIDS
2a) This is the next instalment of @cardiomet_CE’s 10-part #tweetorial foundational series on #lipid management! It is accredited for #CME/CE and intended for #physicians #physicianassociates #nurses #nursepractitioners #pharmacists.#FOAMed @MedTweetorials...